VESALIUS Trademark

Trademark Overview


On Friday, October 1, 2021, a trademark application was filed for VESALIUS with the United States Patent and Trademark Office. The USPTO has given the VESALIUS trademark a serial number of 97055930. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, May 20, 2024. This trademark is owned by Serqet Therapeutics, Inc.. The VESALIUS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders

Research and development of pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders; pharmaceutical research and development
vesalius

General Information


Serial Number97055930
Word MarkVESALIUS
Filing DateFriday, October 1, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, May 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders
Goods and ServicesResearch and development of pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders; pharmaceutical research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 18, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVESALIUS THERAPEUTICS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142

Party NameVESALIUS THERAPEUTICS INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142

Party NameSerqet Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Wednesday, January 19, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, October 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 5, 2022ASSIGNED TO EXAMINER
Thursday, July 7, 2022NON-FINAL ACTION WRITTEN
Thursday, July 7, 2022NON-FINAL ACTION E-MAILED
Thursday, July 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 17, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 17, 2023SOU EXTENSION 1 FILED
Wednesday, May 17, 2023SOU EXTENSION 1 GRANTED
Friday, May 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 16, 2023SOU EXTENSION 2 FILED
Thursday, November 16, 2023SOU EXTENSION 2 GRANTED
Monday, May 20, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 20, 2024SOU EXTENSION 3 GRANTED
Monday, May 20, 2024SOU EXTENSION 3 FILED